Literature DB >> 16550522

Dural venous sinus thrombosis in a patient with sickle cell disease: case report and literature review.

S O Ciurea1, K R Thulborn, M Gowhari.   

Abstract

We report a case of dural venous sinus thrombosis (DVST) in a patient who developed seizures following exchange transfusion for treatment of acute chest syndrome associated with sickle cell disease. Evaluation with magnetic resonance imaging and magnetic resonance venography of the brain indicated left sigmoid sinus thrombosis. The history and laboratory evaluation did not reveal any other inherited or acquired hypercoagulable states. This is the fourth case of dural venous sinus thrombosis associated with sickle cell disease reported in literature. The patient had a favorable outcome with early treatment of unfractionated heparin. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16550522     DOI: 10.1002/ajh.20573

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  Headache and Facial Pain in Sickle Cell Disease.

Authors:  Angeliki Vgontzas; Larry Charleston; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2016-03

Review 2.  Neurologic Complications of Sickle Cell Disease.

Authors:  Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-28       Impact factor: 5.081

Review 3.  Cerebral sinovenous thrombosis in children.

Authors:  Jessica Carpenter; Tammy Tsuchida
Journal:  Curr Neurol Neurosci Rep       Date:  2007-03       Impact factor: 5.081

4.  Woman with Sickle Cell Disease with Current Sigmoid Sinus Thrombosis and History of Inadequate Warfarin Use during a Past Thrombotic Event.

Authors:  Asuman Celikbilek; Mehmet Celikbilek; Alper Bozkurt; Başak Karakurum Göksel; Meliha Tan; Hakan Ozdoğu
Journal:  Case Rep Neurol       Date:  2009-05-16

5.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.